CHD 14
The percentage of patients with a history of myocardial infarction (from 1 April 2011) currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta blocker and statin (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 11 | 2005 | 762 | 970 | 78.6% | |
| CHD 11 | 2006 | 1530 | 1822 | 84.0% | |
| CHD 11 | 2007 | 2030 | 2290 | 88.6% | |
| CHD 11 | 2008 | 2107 | 2367 | 89.0% | |
| CHD 11 | 2009 | 2466 | 2800 | 88.1% | |
| CHD 11 | 2010 | 2796 | 3213 | 87.0% | |
| CHD 11 | 2011 | 3084 | 3538 | 87.2% | |
| CHD 14 | 2012 | 292 | 332 | 87.9% | |
| CHD 14 | 2013 | 538 | 624 | 86.2% | |
| CHD006(S) | 2014 | 634 | 730 | 86.9% | |
| CHD006(S) | 2015 | 864 | 1010 | 85.5% | |
| CHD006(S) | 2016 | 942 | 1088 | 86.6% |
